Several leading companies worldwide focus on the production of complex pharmaceutical APIs, notably Abacavir Sodium sulfate, Abarelix, and Abiraterone Acetate. These substances present significant hurdles in process development due to their molecular sophistication. The manufacturers of these APIs often employ sophisticated processes and adhere to